These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 18035918

  • 1. Doxazosin in metabolically complicated hypertension.
    Dell'Omo G, Penno G, Del Prato S, Pedrinelli R.
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1027-35. PubMed ID: 18035918
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of hypertension in a clinical trial. Depot alpha 1 blocker simplifies dosing].
    Sauerbrey-Wullkopf N, Leverkus F.
    MMW Fortschr Med; 2003 Nov 20; 145(47):54. PubMed ID: 14725035
    [No Abstract] [Full Text] [Related]

  • 5. [Misleading advertising claims about the indication of doxazosin (Cardura) for type 2 diabetes mellitus and hypertension].
    Hoogenberg K, van der Tuin J.
    Ned Tijdschr Geneeskd; 2002 Nov 02; 146(44):2099-100. PubMed ID: 12448967
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension.
    Ceral J, Solar M.
    Blood Press; 2009 Nov 02; 18(1-2):74-7. PubMed ID: 19353415
    [Abstract] [Full Text] [Related]

  • 9. Treating the metabolic syndrome.
    Bianchi C, Penno G, Romero F, Del Prato S, Miccoli R.
    Expert Rev Cardiovasc Ther; 2007 May 02; 5(3):491-506. PubMed ID: 17489673
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The vascular effects of doxazosin in hypertension complicated by metabolic syndrome.
    Dell'Omo G, Penno G, Pucci L, Pellegrini G, Scotti A, Del Prato S, Pedrinelli R.
    Coron Artery Dis; 2005 Feb 02; 16(1):67-73. PubMed ID: 15654203
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of manidipine in the management of patients with hypertension.
    Tikhonoff V, Mazza A, Casiglia E, Pessina AC.
    Expert Rev Cardiovasc Ther; 2004 Nov 02; 2(6):815-27. PubMed ID: 15500427
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Add-on therapy with a nighttime dose of doxazosin in patients with uncontrolled hypertension: effects on autonomic modulation of the cardiovascular system.
    Guzik P, Wykretowicz A, Krauze T, Piskorski J, Adamska K, Milewska A, Wesseling KH, Wysocki H.
    Hypertens Res; 2008 Mar 02; 31(3):443-53. PubMed ID: 18497463
    [Abstract] [Full Text] [Related]

  • 20. Influence of diabetes and cardiovascular disease on the long-term incidence of cataract: the Blue Mountains eye study.
    Tan JS, Wang JJ, Mitchell P.
    Ophthalmic Epidemiol; 2008 Mar 02; 15(5):317-27. PubMed ID: 18850468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.